A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
Cancer immunotherapy has shown significant potential in treating several malignancies by stimulating the host immune system to recognize and attack cancer cells. Immunogenic cell death (ICD) can amplify the antitumor immune responses and reverse the immunosuppressive tumor microenvironment, thus inc...
Saved in:
| Main Authors: | Guojuan Sun, Ling He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1498781/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis
by: Sadique Hussain, et al.
Published: (2024-12-01) -
The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies
by: Dongqi Li, et al.
Published: (2025-12-01) -
Exploring the role of noncoding RNAs in cancer diagnosis, prognosis, and precision medicine
by: Basmah Eldakhakhny, et al.
Published: (2024-12-01) -
The role and function of lncRNA in ageing-associated liver diseases
by: Peyman Kheirandish Zarandi, et al.
Published: (2025-12-01) -
Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs
by: Xiaopeng Hu, et al.
Published: (2025-05-01)